Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

PRP injections may improve hair thickness and density in female hair loss patients.

Minoxidil effectively regrows hair in male pattern baldness.

PRP injections improve hair density and thickness in women with hair loss.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Combining low-level light therapy and minoxidil 5% is more effective for female hair loss than using either treatment alone.

Finasteride shows promise for female hair loss, but more research needed.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Cat color patterns are determined early in development by gene expression and epidermal changes, with the Dickkopf 4 gene playing a crucial role.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

Mast cells might contribute to hair loss by causing skin thickening.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Treat pattern hair loss with finasteride and topical minoxidil.

Hair regrowth doesn't convert thin hairs to thick hairs, but increases overall hair density.

Both methods improve hair density and thickness; double-spin may be more effective.

Adjuvants, diet changes, and laser therapy may improve male pattern hair loss.

Age, gender, and hair loss affect scalp characteristics differently in young Caucasian adults.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Combining light therapy and microneedling shows promise for treating female hair loss.

Ovariectomized mice mimic postmenopausal hair loss, and estradiol helps maintain hair density.

Combination therapy works best for female hair loss, increasing density and thickness.

Dexpanthenol improves hair growth and satisfaction in women without side effects.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

The document concludes that more research is needed to understand hair loss in men and to find new treatments.

Certain gene variations increase male hair loss risk, influenced by hormone levels.